A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women

Arthritis and Rheumatism

Volumn 44, Issue 1, 2001, Pages 196-201

  Ferrari, S L ^a,e   Garnero, P ^b   Emond, S ^a   Montgomery, H ^c   Humphries, S E ^c   Greenspan, S L ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INTERLEUKIN 6; OSTEOCALCIN;

AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FEMUR NECK; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HIP; HUMAN; NORMAL HUMAN; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; RADIUS; RISK FACTOR;

AGED; BONE DENSITY; BONE RESORPTION; COHORT STUDIES; COLLAGEN; FEMALE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0035156066     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5     Document Type: Article

References (33)

1. Perspective: How many women have osteoporosis?
2. Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation
3. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease
4. Bone mass in patients with rheumatoid arthritis
5. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis
6. Biochemical markers of bone turnover: Applications for osteoporosis
7. Serum Crosslaps One Step ELISA: First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type 1 collagen
8. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
9. Markers of bone turnover predict forearm bone loss over 4 years: The OFELY study
10. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial
11. Heritable and nutritional influences on bone mineral mass
12. Prediction of bone density from vitamin D receptor alleles
13. Genetic aspects of osteoporosis
14. Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density
15. Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
16. Association of bone mineral density with polymorphism of the estrogen receptor gene
17. Do dietary calcium and age explain the controversy surrounding the relation between bone mineral density and vitamin D receptor gene polymorphisms?
18. Collagen I-alpha-1 Sp1 polymorphism, bone mass and bone turnover in healthy French premenopausal women: The OFELY study
19. Early postmenopausal bone loss is associated with Pvu II estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy
20. Bone marrow, cytokines and bone remodeling
21. Cellular and molecular mechanisms of osteoporosis
22. Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause
23. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
24. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
25. Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women
26. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
27. Femoral neck osteopenia in patients with inflammatory bowel disease
28. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
29. Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences
30. Association of transforming growth factor β1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis
31. Treatment of postmenopausal osteoporosis